Download this on-demand webinar to learn more about how to reduce GLP-1 waste, achieve sustained progress, and manage costs with tailored, clear plans and support to transition your population off of GLP-1s Meet the speakers David Burdick Director Product Management, Care Solutions, Verily Sarah Thompson, PharmD, MBA Associate Chief Clinical Officer, Clinical Operations Lead, Verily Heidi Guetzkow, TRS Vice President Health Transformation, Aon Lydia R
G., & Leiter, L
Patients avec fatigue chronique ancienne ncessitent protocole plus long (6-8 semaines) pour rsultats stables
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitisstudy design and rationale of HM-TRIA-201 study